Novo Nordisk’s archrival Eli Lilly is stepping up the fight against cheaper copies of Zepbound.
发布者:BY MARKETWIRE IDA JORGENSEN,转转请注明出处:https://robotalks.cn/eli-lilly-lowers-prices-on-weight-loss-treatment/
Novo Nordisk’s archrival Eli Lilly is stepping up the fight against cheaper copies of Zepbound.
发布者:BY MARKETWIRE IDA JORGENSEN,转转请注明出处:https://robotalks.cn/eli-lilly-lowers-prices-on-weight-loss-treatment/